CLOFIBRATE AND THE FIBRINOLYTIC SYSTEM
- 1 February 1969
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 293 (7588), 263-264
- https://doi.org/10.1016/s0140-6736(69)91279-3
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Fibrinolysis and body build: Interrelationships between blood fibrinolysis, body composition and parameters of lipid and carbohydrate metabolismJournal of Atherosclerosis Research, 1968
- EFFECTS OF CLOFIBRATE ON FIBRINOLYSIS, PLATELET STICKINESS, PLASMA-FIBRINOGEN, AND SERUM-CHOLESTEROLThe Lancet, 1968
- Methodological study and a recommended technique for determining the euglobulin lysis timeJournal of Clinical Pathology, 1968
- IMMUNOLOGICAL ASPECTS OF PREMATURE OVARIAN FAILURE ASSOCIATED WITH IDIOPATHIC ADDISON'S DISEASEThe Lancet, 1968
- AUTOIMMUNITY IN GONADAL DYSGENESIS AND KLINEFELTER'S SYNDROMEThe Lancet, 1967
- Effect of biguanides and atromid on fibrinolysisJournal of Atherosclerosis Research, 1967
- The relationship between blood lipids and the fibrinolytic enzyme systemJournal of Atherosclerosis Research, 1966
- Further observations on the effect of ethyl-α-p-chlorophenoxyisobutyrate + androsterone (Atromid) on plasma fibrinogen and serum cholesterol in patients with ischaemic heart diseaseJournal of Atherosclerosis Research, 1966
- ACTIVE HAGEMAN FACTOR: A PLASMA LYSOKINASE OF THE HUMAN FIBRINOLYTIC SYSTEM*JCI Insight, 1962
- Variation in Fibrinolytic Activity After Acute Myocardial Infarction and After the Administration of Oral Anticoagulant Drugs and Intravenous HeparinBritish Journal of Haematology, 1960